Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in ApoptosisRobert C. Briggs, David R. Head, Keith Shults et al.|Cancer Research|2006Cited by 46
Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes Myelodysplastic Syndrome From Normal Bone MarrowSara A. McClintock-Treep, David R. Head, Robert C. Briggs et al.|American Journal of Clinical Pathology|2011Cited by 12
Innovative Analyses Support a Role for DNA Damage and an Aberrant Cell Cycle in Myelodysplastic Syndrome PathogenesisDavid R. Head, Keith Shults, James W. Jacobberger et al.|Bone Marrow Research|2011Cited by 10
Myeloid Nuclear Differentiation Antigen (MNDA) Protein Expression in Myelodysplastic Syndrome (MDS) Is Reduced in Maturing Myeloid Cells.Keith Shults, Robert C. Briggs, David R. Head et al.|Blood|2004Cited by 0
Hematopoietic Progenitors in Myelodysplastic Syndrome (MDS) Demonstrate Cell Cycle Arrest, Mitotic Failure, and DNA Damage.David R. Head, Keith Shults, James W. Jacobberger et al.|Blood|2004Cited by 0